Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 4
2011 3
2012 2
2013 6
2014 5
2015 5
2016 3
2017 2
2018 2
2020 1
2021 1
2022 1
2023 1
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
DNA immunization.
Wang S, Lu S. Wang S, et al. Curr Protoc Microbiol. 2013 Nov 5;31:18.3.1-18.3.24. doi: 10.1002/9780471729259.mc1803s31. Curr Protoc Microbiol. 2013. PMID: 24510291 Free PMC article.
Polyvalent AIDS vaccines.
Lu S, Grimes Serrano JM, Wang S. Lu S, et al. Curr HIV Res. 2010 Dec;8(8):622-9. doi: 10.2174/157016210794088290. Curr HIV Res. 2010. PMID: 21054250 Free PMC article. Review.
Heterologous prime-boost vaccination.
Lu S. Lu S. Curr Opin Immunol. 2009 Jun;21(3):346-51. doi: 10.1016/j.coi.2009.05.016. Epub 2009 Jun 6. Curr Opin Immunol. 2009. PMID: 19500964 Free PMC article. Review.
DNA Immunization for HIV Vaccine Development.
Chen Y, Wang S, Lu S. Chen Y, et al. Vaccines (Basel). 2014 Feb 25;2(1):138-59. doi: 10.3390/vaccines2010138. Vaccines (Basel). 2014. PMID: 26344472 Free PMC article. Review.
Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strains.
Wang S, Chan KW, Wei D, Ma X, Liu S, Hu G, Park S, Pan R, Gu Y, Nazzari AF, Olia AS, Xu K, Lin BC, Louder MK, McKee K, Doria-Rose NA, Montefiori D, Seaman MS, Zhou T, Kwong PD, Arthos J, Kong XP, Lu S. Wang S, et al. Nat Commun. 2024 May 21;15(1):4301. doi: 10.1038/s41467-024-48514-8. Nat Commun. 2024. PMID: 38773089 Free PMC article.
(De-) oiling inflammasomes.
Marty-Roix R, Lien E. Marty-Roix R, et al. Immunity. 2013 Jun 27;38(6):1088-90. doi: 10.1016/j.immuni.2013.06.006. Immunity. 2013. PMID: 23809158 Free PMC article.
Safety and immunogenicity of a polyvalent DNA-protein HIV vaccine with matched Env immunogens delivered as a prime-boost regimen or coadministered in HIV-uninfected adults in the USA (HVTN 124): a phase 1, placebo-controlled, double-blind randomised controlled trial.
Frank I, Li SS, Grunenberg N, Overton ET, Robinson ST, Zheng H, Seaton KE, Heptinstall JR, Allen MA, Mayer KH, Culver DA, Keefer MC, Edupuganti S, Pensiero MN, Mehra VL, De Rosa SC, Morris DE, Wang S, Seaman MS, Montefiori DC, Ferrari G, Tomaras GD, Kublin JG, Corey L, Lu S; HVTN 124 Study Team. Frank I, et al. Lancet HIV. 2024 May;11(5):e285-e299. doi: 10.1016/S2352-3018(24)00036-5. Lancet HIV. 2024. PMID: 38692824 Clinical Trial.
35 results